Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa - Schiffmann, Raphael; Ries, Markus; Blankenship, Derek; Nicholls, Kathy; Mehta, Atul; Clarke, Joe T. R.; Steiner, Robert D.; Beck, Michael; Barshop, Bruce A.; Rhead, William; West, Michael; Martin, Rick; et al. (Genetics in medicine, 2013)
Gesehen am 24.06.2021